Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression
Korhonen, Emilia A, Murtomaki, Aino, Jha, Sawan Kumar, Anisimov, Andrey, Pink, Anne, Zhang, Yan, Stritt, Simon, Liaqat, Inam, Stanczuk, Lukas, Alderfer, Laura, Sun, Zhiliang, Kapiainen, Emmi, Singh, Abhishek, Sultan, Ibrahim, Lantta, Anni, Leppanen, Veli-Matti, Eklund, Lauri, He, Yulong, Augustin, Hellmut G, Vaahtomeri, Kari, Saharinen, Pipsa, Makinen, Taija, Alitalo, Kari
Published in The Journal of clinical investigation (01.08.2022)
Published in The Journal of clinical investigation (01.08.2022)
Get full text
Journal Article
Differential phosphorylation determines the repressor and activator potencies of GLI1 proteins and their efficiency in modulating the HPV life cycle
Piirsoo, Alla, Pink, Anne, Kasak, Lagle, Kala, Martin, Kasvandik, Sergo, Ustav, Mart, Piirsoo, Marko
Published in PloS one (26.11.2019)
Published in PloS one (26.11.2019)
Get full text
Journal Article
Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface
Päll, Taavi, Pink, Anne, Kasak, Lagle, Turkina, Marina, Anderson, Wally, Valkna, Andres, Kogerman, Priit
Published in PloS one (21.12.2011)
Published in PloS one (21.12.2011)
Get full text
Journal Article
DLL4/Notch3/WNT5B axis mediates bidirectional prometastatic crosstalk between melanoma and lymphatic endothelial cells
Alve, Sanni, Gramolelli, Silvia, Jukonen, Joonas, Juteau, Susanna, Pink, Anne, Manninen, Atte A, Hänninen, Satu, Monto, Elisa, Lackman, Madeleine H, Carpén, Olli, Saharinen, Pipsa, Karaman, Sinem, Vaahtomeri, Kari, Ojala, Päivi M
Published in JCI insight (09.01.2024)
Published in JCI insight (09.01.2024)
Get full text
Journal Article
Purification, Characterization and Plasma Half-Life of PEGylated Soluble Recombinant Non-HA-Binding CD44
Pink, Anne, Kallastu, Aili, Turkina, Marina, Skolnaja, Marianna, Kogerman, Priit, Päll, Taavi, Valkna, Andres
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.08.2014)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.08.2014)
Get full text
Journal Article
Antibody and genetic testing in coeliac disease
Wong, Richard C W, Steele, Richard H, Reeves, Glenn E M, Wilson, Robert J, Pink, Anne, Adelstein, Stephen
Published in Pathology (01.08.2003)
Published in Pathology (01.08.2003)
Get full text
Journal Article
Antibody and genetic testing in coeliac disease
Wong, Richard C.W., Steele, Richard H., Reeves, Glenn E.M., Wilson, Robert J., Pink, Anne, Adelstein, Stephen
Published in Pathology (01.08.2003)
Published in Pathology (01.08.2003)
Get full text
Journal Article
PHARMACOLOGICALLY ACTIVE MODIFIED SB101 MOLECULES AND USES THEREOF
KOGERMAN, PRIIT, PALL, TAAVI, PINK, ANNE, SKOLNAJA, MARIANNA, VALKNA, ANDRES, KALLASTU, AILI
Year of Publication 19.02.2015
Get full text
Year of Publication 19.02.2015
Patent
Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation
ANDERSON WALLY, KOGERMAN PRIIT, KASAK LAGLE, ALLIKAS AIRE, PINK ANNE, PALL TAAVI, VALKNA ANDRES
Year of Publication 03.09.2013
Get full text
Year of Publication 03.09.2013
Patent
NOVEL INHIBITOR OF ANGIOGENESIS
ANDERSON WALLY, KOGERMAN PRIIT, KASAK LAGLE, ALLIKAS AIRE, PINK ANNE, PALL TAAVI, VALKNA ANDRES
Year of Publication 26.01.2012
Get full text
Year of Publication 26.01.2012
Patent
NOVEL INHIBITOR OF ANGIOGENESIS
KOGERMAN, PRIIT, PINK, ANNE, ANDDERSON, WALLY, ALLIKAS, AIRE, VALKNA, ANDRES, PAELL, TAAVI, KASAK, LAGLE
Year of Publication 12.05.2010
Get full text
Year of Publication 12.05.2010
Patent
Novel inhibitor of angiogenesis
TAAVI PALL, ANDRES VALKNA, WALLY ANDDERSON, PRIIT KOGERMAN, ANNE PINK, AIRE ALLIKAS, LAGLE KASAK
Year of Publication 22.01.2009
Get full text
Year of Publication 22.01.2009
Patent
NOVEL INHIBITOR OF ANGIOGENESIS
KOGERMAN, PRIIT, PINK, ANNE, ANDDERSON, WALLY, ALLIKAS, AIRE, VALKNA, ANDRES, PAELL, TAAVI, KASAK, LAGLE
Year of Publication 22.01.2009
Get full text
Year of Publication 22.01.2009
Patent